(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Morningside)
Section 19A approved medicine
(Approval lapsed) Oxybutynin hydrochloride 5mg tablets (Morningside)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0478 061 879
Approved until
Status
Expired
Medicines in short supply/unavailable
DITROPAN oxybutynin hydrochloride 5mg tablet bottle AUST R: 48965
Indication(s)
Treatment of detrusor over-activity where conservative measures have failed.
Images
